Evogene Back in Compliance with Nasdaq Rule
Company Announcements

Evogene Back in Compliance with Nasdaq Rule

Evogene (EVGN) has released an update.

Evogene Ltd., a computational biology company, has successfully regained compliance with Nasdaq’s Listing Rule by maintaining a minimum bid price of $1.00 per share over 10 consecutive business days. The company specializes in life-science product discovery using AI and big data, with a focus on developing therapeutics, ag-biologicals, crop protection chemicals, and high-grade industrial biofuels through its subsidiaries.

For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyEvogene announces collaboration with Google Cloud
TheFlyEvogene receives grant from IIA to advance development of ‘MicroFermentor’
TheFlyEvogene files to sell 3.38M ordinary shares for holders
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App